filmov
tv
ΓΔ
0:06:26
Alpha-Beta (αβ) and Gamma-Delta (γδ) T-Cells
0:06:33
Gamma delta T cell
0:02:04
Advances in allogeneic γδ T cells
0:01:31
Prof Dieter Kabelitz - γδ T cells in 90 seconds
0:09:29
Gamma Delta T-Cells
0:01:16
Gene-modified autologous gamma-delta T cells in glioblastoma multiforme
0:03:24
ADI-001: anti-CD20 CAR-engineered allogeneic γδ T cells in adults with B-cell malignancies
1:33:41
The Importance of Gamma-Delta T Cells
0:00:49
The promise of novel multivalent gamma-delta T-cells in the treatment of cancers
0:51:55
Developmental programming of effector gamma-delta T cell subsets by Dr. Bruno Silva Santos
0:27:09
Daniel Olive: Characterization of Vδ2+ γδ T cell populations in breast cancers
0:01:31
Gamma delta T-cell therapy
0:02:01
Expansion and Enrichment of Gamma-Delta T Cells | Protocol Preview
0:01:27
LAVA Therapeutics' Gamma-Delta T Cell Engager Platform
1:19:29
Immune 008: Staying warm with γδ T cells
0:02:16
Phase I study of donor-derived γδ T cells as relapse prophylaxis post haplo/cy
0:00:55
Multivalent gamma-delta T-cells: promising agents for the treatment of cancers
0:02:09
TC BioPharm - safe CAR T therapy based on gamma delta T cells
0:00:58
Advancing glioma treatment using autologous gamma-delta T cells
0:03:02
What was our inspiration for pursuing gamma-delta T cells? Hear from IN8bio’s CEO, William Ho
0:00:57
Why are we combining gamma-delta T cells with chemotherapy?
0:03:01
[Research Highlights] Mast cell engagement of gamma delta T cells protects against viral infection
0:28:21
Why gamma-delta T cells?
0:06:34
Rare Variant: Primary Cutaneous Gamma/Delta T-cell Lymphoma
Вперёд
0:06:26
0:06:33
0:02:04
0:01:31
0:09:29
0:01:16
0:03:24
1:33:41
0:00:49
0:51:55
0:27:09
0:01:31
0:02:01
0:01:27
1:19:29
0:02:16
0:00:55
0:02:09
0:00:58
0:03:02
0:00:57
![[Research Highlights] Mast](https://i.ytimg.com/vi/4TEtfbA535c/hqdefault.jpg)
0:03:01
0:28:21
0:06:34